Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

IBS Software, a leading SaaS provider, sees growth opportunities in India's airlines and loyalty programs. The company aims ...

Sometimes there are clear triggers, but often no clear cause can be found.” Irritable bowel syndrome is a disorder of the ...

67.1% of IBS-C patients in the treatment group met the FDA target for reduction in pain, versus 35.8% in the control group. 66% of IBS-M patients in the treatment group experienced a reduction in ...

Shares of Chipotle Mexican Grill Inc. (CMG) rose 2.7% on Friday after the fast-food chain received an analyst upgrade, and ...

IBS Software Targets Indian Airlines & Loyalty... IBS Software, a leading SaaS provider, sees growth opportunities in India's ...

There are endless possibilities for the reason behind someone’s IBS issues. Stress, diet, oversensitive nerves in your g ...

If you’re dealing with occasional bloating, this spice may help you feel better—and it comes with other digestive perks, too.

Only a small percentage of the population actually needs to avoid gluten, yet millions have jumped on the trend. Here’s what ...

Discover 8 ways mast cell activation syndrome causes widespread symptoms from digestive issues to brain fog, often mistaken ...

Scotiabank initiated coverage of Ardelyx (ARDX) with an Outperform rating and $15 price target The firm sees “an attractive entry point” as it ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...